Filing Details
- Accession Number:
- 0001179110-13-006438
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-04-03 19:50:23
- Reporting Period:
- 2013-04-01
- Filing Date:
- 2013-04-03
- Accepted Time:
- 2013-04-03 19:50:23
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1012140 | Onyx Pharmaceuticals Inc | ONXX | Biological Products, (No Disgnostic Substances) (2836) | 943154463 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1282660 | R Julianna Wood | C/O Onyx Pharmaceuticals, Inc. 249 E. Grand Ave. South San Francisco CA 94080 | Vp, Public Affairs | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2013-04-01 | 438 | $88.86 | 20,281 | No | 4 | F | Direct | |
Common Stock | Disposition | 2013-04-01 | 907 | $86.15 | 19,374 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | F | Direct | |
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 200 | Indirect | Children's Trust |
Footnotes
- Shares sold pursuant to a 10b5-1 arrangement.